GOLDMAN SACHS GROUP INC

Position in TNXP — Tonix Pharmaceuticals Holding Corp.

CIK 886982 NEW YORK, NY

Position in TNXP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,255,022

+$525,516 QoQ

Shares Held

98,356

+85.4% QoQ

Ownership

0.573%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#17

of 103 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. TNXP ranks #244 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,481,761	$1,232,765,138
2	REGN	Regeneron Pharmaceuticals, Inc.	1,163,191	$725,296,113
3	ROIV	Roivant Sciences Ltd.	18,556,458	$656,713,046
4	TECH	BIO-TECHNE Corp	7,343,324	$518,805,838
5	RVMD	Revolution Medicines, Inc.	2,133,101	$399,487,154
6	MRNA	Moderna, Inc.	4,671,950	$327,176,656
7	TNGX	Tango Therapeutics, Inc.	9,980,620	$311,994,180
8	INCY	Incyte Corp	2,305,782	$261,383,446

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,255,022	98,356	+85.4%	Shares	Defined	2026-08-14
2026-03-31	$729,506	53,055	+97.9%	Shares	Defined	2026-05-15
2025-12-31	$418,740	26,808	+110.7%	Shares	Defined	2026-03-25
2025-09-30	$307,363	12,722	-62.8%	Shares	Defined	2025-11-14
2022-09-30	$18,116	34,182	+213.9%	Shares	Defined	2024-05-14
2022-06-30	$17,206	10,890	-97.4%	Shares	Defined	2024-05-14
2022-03-31	$97,714	424,848	-30.6%	Shares	Defined	2022-05-16
2021-12-31	$220,478	612,442	-0.6%	Shares	Defined	2022-02-17
2021-09-30	$369,680	616,135	+1755.8%	Shares	Defined	2022-01-20
2021-06-30	$36,852	33,201	-86.8%	Shares	Defined	2021-08-13
2021-03-31	$322,227	251,740	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.